Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.2402
Delayed Data
As of Apr 19
 -0.0148 / -5.80%
Today’s Change
0.09
Today|||52-Week Range
0.86
+63.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues95.0K0.000.000.00
 
 
Depreciation And Amortization110.0K109.0K20.0K19.0K
 
 
 
 
 
 
Operating ExpensesGross Income---109.0K-20.0K-19.0K
 
 
 
 
General Expenses8.3M12.5M13.7M13.7M
 
 
 
 
 
Research And Development3.6M7.4M9.1M8.8M
 
 
 
 
 
Total Operating Expenses8.4M12.7M13.7M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.3M-12.7M-13.7M-13.8M
 
 
 
 
 
Other Expenses-1.0K-3.0K1.0K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.3M-12.6M-13.7M-13.7M
 
 
 
 
 
Preferred Dividend-4.8M0.000.000.00
 
 
Net Income-8.3M-12.6M-13.7M-13.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.8M17.0M25.2M26.5M
 
 
 
 
 
Shares To Calculate EPS Diluted2.8M17.0M25.2M26.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.67-$0.75-$0.54-$0.51
 
 
 
 
 
EPS Diluted-$4.67-$0.75-$0.54-$0.51